Infliximab as first-line therapy for Crohn's disease is premature.

Inflamm Bowel Dis

Department of Medicine, Mt Sinai Hospital, University of Toronto, Ontario, Canada.

Published: January 2002

Download full-text PDF

Source
http://dx.doi.org/10.1097/00054725-200201000-00011DOI Listing

Publication Analysis

Top Keywords

infliximab first-line
4
first-line therapy
4
therapy crohn's
4
crohn's disease
4
disease premature
4
infliximab
1
therapy
1
crohn's
1
disease
1
premature
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!